Cargando…

Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs

Transformed plasma cells in multiple myeloma (MM) are susceptible to natural killer (NK) cell-mediated killing via engagement of tumor ligands for NK activating receptors or “missing-self” recognition. Similar to other cancers, MM targets may elude NK cell immunosurveillance by reprogramming tumor m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pittari, Gianfranco, Vago, Luca, Festuccia, Moreno, Bonini, Chiara, Mudawi, Deena, Giaccone, Luisa, Bruno, Benedetto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682004/ https://www.ncbi.nlm.nih.gov/pubmed/29163516 http://dx.doi.org/10.3389/fimmu.2017.01444

Ejemplares similares

Role of Allogeneic Transplantation in Multiple Myeloma in the Era of New Drugs
por: Bruno, Benedetto, et al.
Publicado: (2010)

Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies
por: Pittari, Gianfranco, et al.
Publicado: (2015)

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies
por: Chouaib, Salem, et al.
Publicado: (2014)

Natural Killer Cells in the Malignant Niche of Multiple Myeloma
por: Venglar, Ondrej, et al.
Publicado: (2022)

Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers
por: Messaoudene, Meriem, et al.
Publicado: (2017)

The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
por: Cerrano, Marco, et al.
Publicado: (2020)

Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells
por: Scoville, Steven D., et al.
Publicado: (2017)

Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?
por: Lia, Giuseppe, et al.
Publicado: (2021)

Editorial: Tailoring NK Cell Receptor–Ligand Interactions: An Art in Evolution
por: Koehl, Ulrike, et al.
Publicado: (2018)

Next Generation Natural Killer Cells for Cancer Immunotherapy
por: Rossi, Fiorella, et al.
Publicado: (2022)

One-Year Follow-Up of Natural Killer Cell Activity in Multiple Myeloma Patients Treated With Adjuvant Lenalidomide Therapy
por: Besson, Laurie, et al.
Publicado: (2018)

Recurrent Plasmacytomas after Allografting in a Patient with Multiple Myeloma
por: Stawis, Allen N., et al.
Publicado: (2012)

Natural Killer Cells in Asthma
por: Karimi, Khalil, et al.
Publicado: (2013)

Uterine Natural Killer Cells
por: Sojka, Dorothy K., et al.
Publicado: (2019)

Natural Killer Cells in the Lungs
por: Cong, Jingjing, et al.
Publicado: (2019)

Adaptive Features of Natural Killer Cells in Multiple Sclerosis
por: Moreira, Antía, et al.
Publicado: (2019)

Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A
por: Mahaweni, Niken M., et al.
Publicado: (2018)

From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies
por: Tabellini, Giovanna, et al.
Publicado: (2019)

Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells
por: Ismail, Nurul Izza
Publicado: (2023)

Natural Killer Cells and Liver Fibrosis
por: Fasbender, Frank, et al.
Publicado: (2016)

Natural Killer Cells in Antifungal Immunity
por: Schmidt, Stanislaw, et al.
Publicado: (2017)

Unraveling Natural Killer T-Cells Development
por: Bennstein, Sabrina Bianca
Publicado: (2018)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Deciphering Natural Killer Cell Homeostasis
por: Pfefferle, Aline, et al.
Publicado: (2020)

Mechanosensation and Mechanotransduction in Natural Killer Cells
por: Santoni, Giorgio, et al.
Publicado: (2021)

Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells
por: Doherty, Derek G., et al.
Publicado: (2018)

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
por: Barnes, Samantha A., et al.
Publicado: (2021)

The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity
por: Babic, Marina, et al.
Publicado: (2018)

Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors
por: Federici, Cristina, et al.
Publicado: (2020)

NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells
por: Foltz, Jennifer A., et al.
Publicado: (2016)

Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions
por: Wang, Zixi, et al.
Publicado: (2020)

Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma
por: Matchett, Emily C., et al.
Publicado: (2023)

Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era
por: Vieira, Vinicius A., et al.
Publicado: (2022)

Regulation of murine natural killer cell commitment
por: Huntington, Nicholas D., et al.
Publicado: (2013)

MicroRNA regulation of natural killer cells
por: Sullivan, Ryan P., et al.
Publicado: (2013)

Natural Killer Cells Modulation in Hematological Malignancies
por: Baier, Céline, et al.
Publicado: (2013)

Natural killer cells in non-hematopoietic malignancies
por: Desbois, Mélanie, et al.
Publicado: (2012)

Recognition of Microbial Glycolipids by Natural Killer T Cells
por: Zajonc, Dirk M., et al.
Publicado: (2015)

Manufacturing Natural Killer Cells as Medicinal Products
por: Chabannon, Christian, et al.
Publicado: (2016)

Immunometabolic Activation of Invariant Natural Killer T Cells
por: Ververs, Francesca A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ccsjuppttsso2rv8t569into28